Get the Stockscreener App
88.37
0.64%
0.56
After Hours:
88.37
Dexcom Inc stock is traded at $88.37, with a volume of 4.31M.
It is up +0.64% in the last 24 hours and up +1.77% over the past month.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
See More
Previous Close:
$87.81
Open:
$87.84
24h Volume:
4.31M
Relative Volume:
1.29
Market Cap:
$35.41B
Revenue:
$4.03B
Net Income/Loss:
$576.20M
P/E Ratio:
61.80
EPS:
1.43
Net Cash Flow:
$630.70M
1W Performance:
-0.46%
1M Performance:
+1.77%
6M Performance:
+27.44%
1Y Performance:
-23.20%
1-Day Range:
$86.79
$88.60
1-Week Range:
$86.41
$91.87
52-Week Range:
$62.34
$142.00
Dexcom Inc Stock (DXCM) Company Profile
Name
Dexcom Inc
Sector
Industry
Phone
(858) 200-0200
Address
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Compare DXCM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
88.37 | 35.41B | 4.03B | 576.20M | 630.70M | 1.43 |
|
ABT
Abbott Laboratories
|
138.01 | 239.35B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
103.79 | 153.17B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
386.19 | 147.36B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.02 | 118.00B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.62 | 42.24B | 5.72B | 4.17B | 490.10M | 6.97 |
Dexcom Inc Stock (DXCM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-03-25 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Jan-16-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jul-26-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-26-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-30-24 | Initiated | Redburn Atlantic | Neutral |
| Mar-12-24 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-17-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Mar-29-23 | Initiated | UBS | Buy |
| Jan-26-23 | Initiated | Wolfe Research | Outperform |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-15-22 | Initiated | Bernstein | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-03-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-19-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-07-22 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-18-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-28-21 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Jan-06-21 | Upgrade | UBS | Neutral → Buy |
| Oct-02-20 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| May-27-20 | Reiterated | Piper Sandler | Overweight |
| May-14-20 | Initiated | Wells Fargo | Equal Weight |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Nov-07-19 | Reiterated | Canaccord Genuity | Buy |
| Nov-07-19 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-23-19 | Initiated | Stifel | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Oct-19-18 | Upgrade | Goldman | Sell → Neutral |
| Sep-12-18 | Upgrade | Northland Capital | Under Perform → Market Perform |
| Aug-02-18 | Reiterated | Canaccord Genuity | Buy |
| Jul-02-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-08-18 | Upgrade | JP Morgan | Neutral → Overweight |
| May-11-18 | Initiated | BofA/Merrill | Buy |
| May-03-18 | Reiterated | Canaccord Genuity | Buy |
| Apr-04-18 | Initiated | Goldman | Sell |
| Apr-04-18 | Initiated | Guggenheim | Neutral |
| Mar-23-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-04-18 | Downgrade | Northland Capital | Market Perform → Under Perform |
| Sep-28-17 | Reiterated | Wedbush | Outperform |
View All
Dexcom Inc Stock (DXCM) Latest News
26,263 Shares in DexCom, Inc. (NASDAQ:DXCM) Bought by First American Bank - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Stake Decreased by Taylor Frigon Capital Management LLC - MarketBeat
Y Intercept Hong Kong Ltd Sells 47,164 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Amalgamated Bank Sells 3,208 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Shares Purchased by Brown Financial Advisors - MarketBeat
Union Bancaire Privee UBP SA Makes New Investment in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Sanctuary Advisors LLC Raises Stock Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Shareholders That Lost Money on DexCom, Inc. (DXCM) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Shareholders That Lost Money on DexCom, Inc. (DXCM) Should Contact Levi & Korsinsky About Pending Class ActionDXCM - ACCESS Newswire
Shareholders that lost money on DexCom, Inc.(DXCM) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
DexCom, Inc. (NASDAQ:DXCM) Shares Sold by National Pension Service - MarketBeat
Private Advisor Group LLC Acquires 3,831 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Q4 2024 Earnings Call Transcript - MSN
South Dakota Investment Council Increases Stock Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
HealthInvest Partners AB Boosts Stake in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Dexcom Announces Upcoming Conference Presentation - The Bakersfield Californian
How Will Dexcom's Upcoming Raymond James Conference Presentation Impact Investor Outlook? - StockTitan
Investors Will Want DexCom's (NASDAQ:DXCM) Growth In ROCE To Persist - Yahoo Finance
FUKOKU MUTUAL LIFE INSURANCE Co Makes New Investment in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Shares Bought by Los Angeles Capital Management LLC - MarketBeat
Pinnacle Financial Partners Inc Trims Stake in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
1,241,721 Shares in DexCom, Inc. (NASDAQ:DXCM) Purchased by Fisher Funds Management LTD - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Dexcom diabetes monitoring device facing national shortage - FOX21News.com
DXCM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Got $200? 2 Healthcare Stocks to Buy and Hold Forever - The Motley Fool
D.A. Davidson & CO. Decreases Stock Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom Stock Outlook: Is Wall Street Bullish or Bearish? - MSN
ATTENTION DexCom, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights - ACCESS Newswire
DexCom, Inc. Class Action: Levi & Korsinsky Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024DXCM - ACCESS Newswire
Shareholders that lost money on DexCom, Inc.(DXCM) should contact Levi & Korsinsky about pending Class ActionDXCM - ACCESS Newswire
Diabetes Care Devices Market Massive Growth opportunity Ahead | Medtronic, Abbott, Dexcom - openPR
Ieq Capital LLC Buys 31,641 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
The Zacks Analyst Blog Highlights AbbVie, Amgen, Stryker, Dexcom and Medtronic - Yahoo Finance
DexCom, Inc. (NASDAQ:DXCM) Shares Sold by Principal Financial Group Inc. - MarketBeat
Dexcom Inc.: Will Sensor Tech Advancements Solidify Its Lead In Continuous Glucose Monitoring? - Smartkarma
DexCom, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your RightsDXCM - ACCESS Newswire
Shareholders of DexCom, Inc. Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your RightsDXCM - ACCESS Newswire
DexCom (DXCM) Fell Due to an Uncharacteristic Earnings Miss - MSN
Alberta Investment Management Corp Purchases 36,500 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DXCM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Lost Money on DexCom, Inc.(DXCM)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Levi & Korsinsky Announces an Investigation on Behalf of DexCom, Inc. (DXCM) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire
GAM Holding AG Sells 23,609 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom's SWOT analysis: stock faces challenges amid growth potential - MSN
Glucose Biosensor Market to Witness Remarkable Growth with Abbott Laboratories, Dexcom, F. Hoffmann-La Roche - EIN News
Earnings Miss: DexCom, Inc. Missed EPS By 7.8% And Analysts Are Revising Their Forecasts - Simply Wall St
Ownership Capital B.V. Decreases Stake in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Cardinal Capital Management Makes New Investment in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Jim Cramer: This Energy Stock Is A Buy, Stay Away From DexCom - MSN
Peregrine Capital Management LLC Sells 29,135 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Dexcom Inc Stock (DXCM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Dexcom Inc Stock (DXCM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Dolan Matthew Vincent | EVP, Strategy & Corporate Dev |
Jan 29 '25 |
Sale |
86.91 |
1,183 |
102,820 |
42,044 |
| Stern Sadie | EVP, Chief HR Officer |
Jan 29 '25 |
Sale |
86.91 |
2,093 |
181,911 |
74,261 |
| Leach Jacob Steven | EVP, Chief Operating Officer |
Jan 29 '25 |
Sale |
86.91 |
2,634 |
228,932 |
268,644 |
| SAYER KEVIN R | Chairman, CEO & President |
Jan 29 '25 |
Sale |
86.91 |
33,359 |
2,899,367 |
319,037 |
| Stern Sadie | EVP, Chief HR Officer |
Dec 16 '24 |
Sale |
76.87 |
424 |
32,593 |
70,768 |
| Sylvain Jereme M | EVP, Chief Financal Officer |
Dec 16 '24 |
Sale |
76.87 |
744 |
57,191 |
80,030 |
| Leach Jacob Steven | EVP, Chief Operating Officer |
Dec 16 '24 |
Sale |
76.87 |
744 |
57,191 |
264,171 |
| Heller Bridgette P | Director |
Dec 16 '24 |
Sale |
76.87 |
1,000 |
76,870 |
23,349 |
2.29%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):